Platelets blood test
Platelet count (PLT). Also called: Platelet count, PLT, Thrombocytes
Platelet count blood test: what it measures, Labcorp and Quest ranges, what raises and lowers platelets, why a low count is sometimes a tube artefact, and 18 peptides with measured effects.
Part of the complete blood count (CBC). The panel page lists every value on the report.
At a glance
| What it measures | The number of platelets, the small cells that prevent bleeding, in a volume of whole blood |
|---|---|
| Units | x10E3/uL (thousands per microliter; Quest writes Thousand/uL); the same number as x10^9/L |
| Labcorp adult range | 150-450 x10E3/uL |
| Quest range | 140-400 Thousand/uL for anyone over 6 months |
| Sample | Whole blood in an EDTA (lavender-top) tube, kept at room temperature; no fasting listed |
| Ordered as | Part of every complete blood count (CBC), or alone (Labcorp 005249, Quest 723) |
| Peptides with data | 18, mostly hospital drugs such as Eptifibatide and Angiotensin II; BPC-157 has rat data only |
What are Platelets?
Platelets are specialized cells that prevent bleeding and minimize blood vessel injury. The platelet count reports how many are in a volume of whole blood and is part of every complete blood count. The same report usually gives the mean platelet volume (MPV), an index of platelet size.
A count outside the range is common and often has an everyday cause, from inflammation to a clumped sample. Very low counts carry a bleeding risk, and some causes of low platelets, such as heparin-induced thrombocytopenia, carry a high risk of clots instead.
How it is made and regulated
Where it is made
Platelets come from large progenitor cells in the bone marrow called megakaryocytes. As they mature, megakaryocytes become polyploid and build up large amounts of protein and membrane; they then extend long branching processes (proplatelets) into the bone marrow blood vessels, where the processes break up to release platelets.
Sources: [1]
What controls it
Baseline platelet production depends on the hormone thrombopoietin (TPO). TPO is made at a steady rate and is regulated mainly by uptake onto platelets themselves, so the platelet mass helps set how much TPO is available.
Inflammation adds a second route. Interleukin-6 raises TPO production in the liver, and in mice IL-6-induced thrombocytosis was abolished when TPO was neutralized. IL-6 also drives the liver's CRP response, so platelets and CRP can rise together in acute inflammation; no direct causal link between them is established. In 16,329 NHANES participants, mean platelet volume was inversely related to CRP.
How it travels in the blood
Platelets circulate as cells in whole blood, and the count is only as good as the sample. In EDTA, the usual anticoagulant, some people's platelets clump in the tube. The analyzer then counts the clumps as fewer platelets, an artefact called EDTA-induced pseudothrombocytopenia.
Platelet size is reported as MPV. In 326 healthy adults, 95% had an MPV between 7.2 and 11.7 fL. MPV drifts upward over time in EDTA tubes, so a delayed sample reads larger.
How long it lasts
Platelets have no nucleus, but their lifespan is still set by a cell-death program. The survival protein Bcl-x(L) restrains the killer protein Bak; when Bak is released, the platelet undergoes apoptosis. Changes to this program change platelet lifespan in the body.
Sources: [10]
What it does
Platelets prevent bleeding and limit blood vessel injury. With very low counts the risk of spontaneous bleeding rises: AABB guidance transfuses hospitalized adults with treatment-related low platelets at 10 x10^9/L or less.
Too many platelets can have the opposite problem. In essential thrombocythemia, a bone marrow disorder diagnosed only after other myeloid disorders are excluded, the main goal of treatment is preventing thrombosis.
Reference ranges
Labcorp prints its CBC ranges on published sample reports; Quest lists an age-banded range for its platelet count test. Quest writes the unit as Thousand/uL, which is the same as x10E3/uL.
Labcorp (test 005009)
| Group | Range (x10E3/uL) |
|---|---|
| Adults (sample reports for women aged 46 and 60) | 150-450 |
Children and teens
| Group | Range (x10E3/uL) |
|---|---|
| Boys, 15 years (sample report) | 150-450 |
Ranges as printed on Labcorp's published sample reports for tests 005009 (2026 and 2024) and 028142 (2020).
Quest Diagnostics (test 723)
| Group | Range (x10E3/uL) |
|---|---|
| Over 6 months | 140-400 |
Children and teens
| Group | Range (x10E3/uL) |
|---|---|
| 4 days to 6 months | 150-400 |
| 3 days or younger | 150-450 |
Quest publishes this range in Thousand/uL (the same as x10E3/uL).
Use the range printed on your own report. A single result just outside the range, in someone who feels well, is often repeated before anything else is done.
What raises it
| Factor | How | How much |
|---|---|---|
| Inflammation (reactive thrombocytosis)Condition | Interleukin-6 raises thrombopoietin production in the liver, which drives platelet production. | No published magnitude [5] |
| Strenuous exerciseLifestyle | Platelet count and MPV both rose after a half-marathon and returned to baseline within 3 hours. | No published magnitude [16] |
| Essential thrombocythemiaCondition | A JAK2-mutation-prevalent bone marrow disorder with clonal thrombocytosis; diagnosis requires platelets of 450 x10^9/L or more and exclusion of other myeloid disorders. | No published magnitude [12] |
What lowers it
| Factor | How | How much |
|---|---|---|
| Heparin-induced thrombocytopeniaMedication | Platelet-activating antibodies against platelet factor 4-heparin complexes lower the count and markedly raise the risk of clots. | No published magnitude [4] |
| Chemotherapy and other marrow-suppressing treatmentMedication | Treatment-induced (hypoproliferative) thrombocytopenia; AABB guidance covers when to transfuse. | AABB: transfuse hospitalized adults at 10 x10^9/L or less; consider at under 20 x10^9/L for a central line and under 50 x10^9/L for lumbar puncture or major elective surgery [11] |
| EDTA-induced clumping (pseudothrombocytopenia)Condition | Platelets clump in the EDTA tube, so the count reads falsely low; confirm with counts on citrate or heparin and a blood smear. | No published magnitude [3] |
Peptides that affect Platelets
Peptides with measured effects on platelet count, from human trials, FDA labels and named animal studies. Several are anticoagulants or vasopressors used in hospital, where low platelets are a known risk. "No clear effect" rows were measured; they are not inferred.
| Peptide | Effect on Platelets | Size of effect | Evidence |
|---|---|---|---|
| Angiotensin 1-7 | Raises | Phase 2, 34 women on chemotherapy: the maximal percentage rise in platelets from baseline was higher on 100 mcg/kg than placebo (p=0.02); no grade 4 thrombocytopenia on 100 mcg/kg vs 6% of placebo cycles (p=0.07); 300 mcg/kg did not differ from placeboA small trial; the same dose lowered the neutrophil nadir (see the WBC page). [17] | Human trials |
| Hirudin | Raises | Patients with heparin-induced thrombocytopenia, no placebo group. Label (HAT-1 and HAT-2, patients with thromboembolic complications): platelet recovery, a rise of at least 30% from the nadir to above 100,000, in 90.9% and 95.0% of evaluable patients. Prospective study of 112 patients: complete laboratory response, which required platelet normalization by day 10 plus effective anticoagulation, in 69.1%Lepirudin replaces heparin in heparin-induced thrombocytopenia, so platelet counts recover. [18] [19] | Human trials |
| IGF-1 (Insulin-Like Growth Factor 1) | Lowers | Children with Laron syndrome on IGF-I therapy: platelets fell from 316 to 219 x10^3/ml (p=0.02)An effect the authors called not previously described. [20] | Human trials |
| Melanotan I | Lowers | 38 patients with erythropoietic protoporphyria on afamelanotide: mean platelets 196.6 to 184.8 x1000/uL (p=0.0121), staying within the normal rangeA small fall within normal limits. [21] | Human trials |
| Terlipressin | Lowers | Septic shock (TERLIVAP, randomized vs vasopressin and norepinephrine): a time-dependent fall in platelet count occurred only in the terlipressin group (P<0.001, 48 hours vs baseline)Platelets fell with terlipressin but not with the two comparators. [22] | Human trials |
| Carbetocin | No clear effect | Measured, no difference: slow infusion of carbetocin or oxytocin gave similar platelet counts at all time points (p>0.05)Hemostatic tests did not differ from oxytocin. [23] | Human trials |
| Enkephalin (Met-enkephalin / Leu-enkephalin) | No clear effect | Measured, no change: no statistical change in hematologic values from baseline during [Met5]-enkephalin infusionsHematology was monitored and did not move. [24] | Human trials |
| Teriparatide | No clear effect | Measured, no change: 23 postmenopausal women on 20 mcg daily for 24 months; no differences in complete blood count profiles, which included plateletsThe routine blood count did not change. [25] | Human trials |
| Vasopressin | No clear effect | Measured, no fall: in the same septic shock trial, platelet count decreased only with terlipressin, not with vasopressinVasopressin did not lower platelets in this comparison. [22] | Human trials |
| Bivalirudin | Unclear | Pooled HORIZONS-AMI and EUROMAX data: thrombocytopenia in 1.4% on bivalirudin vs 2.9% on heparin with or without GP IIb/IIIa inhibitors. Label: 2 of 51 patients with HIT developed thrombocytopenia after bivalirudin plus GP IIb/IIIa inhibitorsLess thrombocytopenia than heparin-based regimens, but cases still occur; there is no placebo comparison. [26] [27] | Human trials |
| Angiotensin II | Lowers | Label (ATHOS-3, vasodilatory shock): thrombocytopenia in 9.8% on angiotensin II vs 7.0% on placeboReported somewhat more often than placebo in critically ill patients. [28] | FDA label |
| Desmopressin | Lowers | No rate given: the label warns that in type IIB von Willebrand disease desmopressin may cause platelet aggregation, thrombocytopenia and possibly thrombosisA risk confined to one von Willebrand subtype. [29] | FDA label |
| Eptifibatide | Lowers | Label: thrombocytopenia (under 100,000/mm3 or a 50% or greater fall) in 1.2% on eptifibatide vs 0.6% on placebo in ESPRIT; rates were similar to placebo in PURSUIT and IMPACT IIA glycoprotein IIb/IIIa blocker; platelet counts are monitored during infusion. [30] | FDA label |
| Exenatide | Lowers | Label: contraindicated after drug-induced immune-mediated thrombocytopenia from exenatide; serious, sometimes fatal bleeding reported. Case report: platelets 1,000/uL after 11 weekly injections, down from 165,000/uLRare, antibody-mediated, and severe when it happens. [31] [32] | FDA label |
| Octreotide | Lowers | Label: thrombocytopenia reported after approval (rate unknown). Case report: platelets fell from 155,000/mm3 to 77,000/mm3 within hours of starting octreotide and recovered after stoppingRare; recognised mainly from post-marketing reports and cases. [33] [34] | FDA label |
| BPC-157 | Raises | Rats after tail amputation given heparin or warfarin: BPC 157 reduced bleeding and counteracted thrombocytopeniaRat data only; no human platelet data exist. [35] | Animal studies |
| Ghrelin | Raises | Mice after radiation with or without a skin wound: ghrelin therapy recovered platelet counts on days 7 and 15Mouse radiation-injury data only. [36] | Animal studies |
| LL-37 | No clear effect | Measured, no change: mice given intranasal LL-37 had platelet counts no different from saline controlsMouse data from a lung-injury model. [37] | Animal studies |
What high or low results can mean
A high result
A count above the range is thrombocytosis. Inflammation is a common driver, through interleukin-6 and thrombopoietin. A bone marrow cause such as essential thrombocythemia is diagnosed only after other myeloid disorders are excluded.
- Inflammation or infection (reactive thrombocytosis)
- Recent strenuous exercise (short-lived)
- Essential thrombocythemia and other myeloproliferative disorders
A low result
A count below the range is thrombocytopenia. First rule out an artefact: EDTA clumping can make the count read falsely low in someone with no symptoms. True low counts raise bleeding risk as they fall, and heparin-induced thrombocytopenia raises clot risk instead.
- EDTA-induced clumping in the tube (artefact)
- Heparin-induced thrombocytopenia
- Chemotherapy or other marrow-suppressing treatment
- Drug-induced immune thrombocytopenia (for example from exenatide)
How the test works
| Sample | Whole blood from a full EDTA (lavender-top) tube, 1 mL (0.5 mL in a microtainer). Quest asks for room temperature and no refrigeration: refrigeration can precipitate fibrin that traps platelets, and a traumatic draw can introduce thromboplastin. |
|---|---|
| Fasting | Neither Labcorp nor Quest lists fasting for a platelet count. |
| Timing | Avoid strenuous exercise just before the draw: platelet count and MPV rose after a half-marathon and took up to 3 hours to return to baseline. |
| Lab differences | Quest counts platelets by electronic cell sizing on an automated analyzer and lists 48-hour room-temperature stability. In a study on another analyzer, platelet counts were stable for only 12 hours at room temperature, so a delayed sample can mislead. |
| Retesting | Platelet counts vary more than red-cell values from test to test: within-person variation for platelet and white-cell values was 5% to 15% in a 2019 meta-analysis. |
| Labcorp order code | 005249: Platelet Count |
| Quest Diagnostics order code | 723: Platelet Count, EDTA |
| LOINC codes |
|
History
Three recent consensus documents standardized how low platelet counts are named and acted on.
- 2009An international working group standardizes the terminology, definitions and outcome criteria for immune thrombocytopenia (ITP) in adults and children. [41]
- 2015The AABB publishes platelet transfusion thresholds, including transfusion at 10 x10^9/L or less for hospitalized adults with treatment-related low counts. [11]
- 2018The American Society of Hematology issues guidelines for heparin-induced thrombocytopenia, recommending the 4Ts score to estimate its probability. [4]
FAQ
What is a normal platelet count?
Labcorp prints 150-450 x10E3/uL for adults, and Quest lists 140-400 Thousand/uL (the same unit) for anyone over 6 months. Use the range on your own report.
What counts as a high platelet count?
A count above the range is thrombocytosis. Inflammation can raise platelets through interleukin-6 and thrombopoietin. For essential thrombocythemia, a bone marrow disorder, the diagnostic threshold is 450 x10^9/L or more, and other myeloid disorders must be excluded first.
How low is dangerously low?
There is no single number for everyone. AABB guidance transfuses hospitalized adults with treatment-related low platelets at 10 x10^9/L or less, and suggests transfusing below 20 x10^9/L before a central line and below 50 x10^9/L before a lumbar puncture or major elective surgery.
Sources: [11]
Why would a lab repeat my platelet count in a different tube?
Some people's platelets clump in EDTA, the usual tube additive, so the analyzer reads a falsely low count. Serial counts on citrate or heparin tubes and a blood smear confirm it.
Sources: [3]
Can heparin lower platelets?
Yes. In heparin-induced thrombocytopenia, antibodies against platelet factor 4-heparin complexes activate platelets, the count falls, and the risk of clots rises sharply. ASH recommends the 4Ts score to judge how likely it is.
Sources: [4]
Are platelets linked to CRP?
Both rise with interleukin-6 in acute inflammation; no direct causal link is established. IL-6 drives reactive thrombocytosis through thrombopoietin, and it also drives CRP. In NHANES (16,329 participants), mean platelet volume was inversely related to CRP: people with high CRP had a lower MPV.
What is MPV?
Mean platelet volume is the average platelet size. In 326 healthy adults, 95% had an MPV between 7.2 and 11.7 fL. MPV rises with time in EDTA tubes, and studies link high and low MPV to different inflammatory conditions, but a clinical cutoff is not established.
Does exercise change the platelet count?
Briefly. Platelet count and MPV rose after a half-marathon and returned to baseline within 3 hours.
Sources: [16]
Should my sample be refrigerated?
No. Quest asks that platelet samples stay at room temperature, because refrigeration can precipitate fibrin that traps platelets. Delays also matter: one study found platelet counts stable for only 12 hours at room temperature.
Which peptides affect the platelet count?
Most of the data concern hospital drugs. Eptifibatide, Angiotensin II and Terlipressin lowered counts in trials, and Exenatide and Octreotide have rare drug-induced cases. Angiotensin 1-7 raised platelets in a small chemotherapy trial. BPC-157 has only rat data. The full table is above.
How much does the platelet count vary between tests?
More than red-cell values: within-person variation for platelet counts was in the 5% to 15% range in a 2019 meta-analysis. A small change between two results is usually noise.
Sources: [39]
References
- Machlus KR, Italiano JE. The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol. 2013;201(6):785-96. PMID 23751492
- Korniluk A, Koper-Lenkiewicz OM, Kamińska J, et al. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators Inflamm. 2019;2019:9213074. PMID 31148950
- Lim ECN, Lim CED. The Phantom Platelet Problem: Unmasking Ethylenediaminetetraacetic Acid (EDTA)-Induced Pseudo-Thrombocytopenia. Cureus. 2025;17(3):e81211. PMID 40151481
- Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360-3392. PMID 30482768
- Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98(9):2720-5. PMID 11675343
- Narazaki M, Kishimoto T. The Two-Faced Cytokine IL-6 in Host Defense and Diseases. Int J Mol Sci. 2018;19(11). PMID 30423923
- Ball S, Dennis JA, Bedanie G, et al. Relation between mean platelet volume and C-reactive protein. Proc (Bayl Univ Med Cent). 2020;33(2):163-168. PMID 32313453
- Demirin H, Ozhan H, Ucgun T, et al. Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study. Thromb Res. 2011;128(4):358-60. PMID 21620440
- O'Malley T, Ludlam CA, Fox KA, et al. Measurement of platelet volume using a variety of different anticoagulant and antiplatelet mixtures. Blood Coagul Fibrinolysis. 1996;7(4):431-6. PMID 8839994
- Josefsson EC, White MJ, Dowling MR, et al. Platelet life span and apoptosis. Methods Mol Biol. 2012;788:59-71. PMID 22130700
- Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205-13. PMID 25383671
- Tefferi A, Vannucchi AM, Barbui T. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024;99(4):697-718. PMID 38269572
- Labcorp. Sample report, test 005009 (CBC With Differential/Platelet): reference intervals as printed for a 46-year-old woman (reported 09/15/2026) and a 15-year-old boy (reported 10/23/2024). files.labcorp.com/testmenu-d8/sample_reports/005009.pdf
- Labcorp. Sample report, test 028142 (CBC, Platelet, No Differential): reference intervals as printed for a 60-year-old woman (reported 01/27/2020). files.labcorp.com/testmenu-d8/sample_reports/028142.pdf
- Quest Diagnostics. Test 723: Platelet Count, EDTA. Test directory: specimen, stability, methodology and age-banded reference range. testdirectory.questdiagnostics.com/test/test-detail/723/platelet-count-edta?cc=PHP
- Lippi G, Salvagno GL, Danese E, et al. Variation of red blood cell distribution width and mean platelet volume after moderate endurance exercise. Adv Hematol. 2014;2014:192173. PMID 25197280
- Pham H, Schwartz BM, Delmore JE, et al. Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy. Cancer Chemother Pharmacol. 2013;71(4):965-72. PMID 23370663
- Greinacher A, Janssens U, Berg G, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators. Circulation. 1999;100(6):587-93. PMID 10441094
- Refludan (lepirudin). FDA prescribing information. accessdata.fda.gov/drugsatfda_docs/label/2006/020807s011lbl.pdf
- Sivan B, Lilos P, Laron Z. Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metab. 2003;16(4):509-20. PMID 12793602
- Minder AE, Barman-Aksoezen J, Schmid M, et al. Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study. Ther Adv Rare Dis. 2021;2:26330040211065453. PMID 37181106
- Morelli A, Ertmer C, Rehberg S, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13(4):R130. PMID 19664253
- Yoruk N, Aksoy AN, Kadioglu BG, et al. The effects of oxytocin and carbetocin on hemostatic parameters in women after spontaneous vaginal delivery: a randomized trial. Rev Assoc Med Bras (1992). 2026;72(2):e20251346. PMID 42018849
- Smith JP, Bingaman SI, Mauger DT, et al. Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer. Open Access J Clin Trials. 2010;2010(2):37-48. PMID 20890374
- Yu EW, Kumbhani R, Siwila-Sackman E, et al. Teriparatide (PTH 1-34) treatment increases peripheral hematopoietic stem cells in postmenopausal women. J Bone Miner Res. 2014;29(6):1380-6. PMID 24420643
- Stone GW, Mehran R, Goldstein P, et al. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. J Am Coll Cardiol. 2015;65(1):27-38. PMID 25572507
- Bivalirudin for injection. FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42aa2630-83d6-433d-8277-0f672cf8d71d
- Giapreza (angiotensin II). FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c265d69a-3efe-4107-9a9e-e6fd3d531c48
- DDAVP injection (desmopressin acetate). FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=651f6fee-a2c7-431b-8d5d-58b156c72244
- Eptifibatide injection. FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0781dae-3ef6-4cab-b084-01d2e45f3764
- Byetta (exenatide). FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f
- Vallatharasu Y, Hayashi-Tanner Y, Polewski PJ, et al. Severe, prolonged thrombocytopenia in a patient sensitive to exenatide. Am J Hematol. 2019;94(3):E78-E80. PMID 30575104
- Octreotide acetate injection. FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9502860d-0261-4d69-a4be-827a5376d356
- Rashidi A, Rizvi N. Octreotide-induced thrombocytopenia: a case report. J Med Case Rep. 2011;5:286. PMID 21729263
- Stupnisek M, Kokot A, Drmic D, et al. Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. PLoS One. 2015;10(4):e0123454. PMID 25897838
- Kiang JG, Anderson MN, Smith JT. Ghrelin therapy mitigates bone marrow injury and splenocytopenia by sustaining circulating G-CSF and KC increases after irradiation combined with wound. Cell Biosci. 2018;8:27. PMID 29632660
- Chi Y, Peng Y, Zhang S, et al. A Rapid In Vivo Toxicity Assessment Method for Antimicrobial Peptides. Toxics. 2024;12(6). PMID 38922067
- Schapkaitz E, Pillay D. Prolonged storage-induced changes in haematology parameters referred for testing. Afr J Lab Med. 2015;4(1):208. PMID 38440305
- Coskun A, Braga F, Carobene A, et al. Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters. Clin Chem Lab Med. 2019;58(1):25-32. PMID 31503541
- LOINC 777-3: Platelets [#/volume] in Blood by Automated count. Regenstrief Institute. loinc.org/777-3
- Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-93. PMID 19005182
Educational information, not medical advice. Lab ranges and test codes were checked on October 30, 2026. Always use the range printed on your own report, and talk to a clinician about your results.